Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Duensing · SciRah

Researcher profile · Semantic Scholar

S. Duensing

Share profile

S. Duensing — researcher profile on SciRah

h-index: 54
Works: 205
Citations: 10K

Most-cited papers

Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
J. Radtke, C. Schwab, M. Wolf, Martin T. Freitag +15 more
2016European Urology310 citations
Semantic Scholar
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
J. Radtke, M. Wiesenfarth, C. Kesch, Martin T. Freitag +13 more
2017European Urology183 citations
Semantic Scholar
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
M. Hupe, Christian Philippi, Doris Roth, C. Kümpers +11 more
2018Frontiers in Oncology165 citations Open access
Semantic Scholar
An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study
M. Görtz, Kilian Baumgärtner, Tamara Schmid, Marc Muschko +6 more
2023Digital Health91 citations Open access
Semantic Scholar
Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
C. Kesch, M. Vinsensia, J. Radtke, H. Schlemmer +16 more
2017Journal of Nuclear Medicine89 citations
Semantic Scholar
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
J. Brägelmann, N. Klümper, A. Offermann, A. von Mässenhausen +17 more
2016Clinical Cancer Research81 citations Open access
Semantic Scholar
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes
C. Kratochwil, F. Giesel, C. Heussel, Daniel Kazdal +11 more
2019Journal of Nuclear Medicine80 citations
Semantic Scholar
Identification of cell-free microRNAs in the urine of patients with prostate cancer.
N. Korzeniewski, G. Tosev, S. Pahernik, B. Hadaschik +2 more
2015Urologic oncology70 citations
Semantic Scholar
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer
Angela Queisser, S. Hagedorn, M. Braun, W. Vogel +2 more
2015Modern Pathology64 citations Open access
Semantic Scholar
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Rouven Hoefflin, B. Lahrmann, Gregor Warsow, D. Hübschmann +25 more
2016Nature Communications63 citations Open access
Semantic Scholar
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
J. Nyarangi-Dix, M. Wiesenfarth, D. Bonekamp, Bertram Hitthaler +11 more
2020European Urology Focus61 citations
Semantic Scholar
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
V. Sailer, G. von Amsberg, S. Duensing, J. Kirfel +10 more
2022Nature reviews. Urology60 citations
Semantic Scholar
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
M. Jenzer, Peter Keß, Cathleen Nientiedt, V. Endris +17 more
2019Cancer Immunology and Immunotherapy49 citations Open access
Semantic Scholar
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
S. Dieffenbacher, J. Nyarangi-Dix, F. Giganti, D. Bonekamp +12 more
2019European Urology Focus46 citations Open access
Semantic Scholar
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
J. M. Pickl, D. Tichy, V. Kuryshev, Y. Tolstov +11 more
2016OncoTarget43 citations Open access
Semantic Scholar
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard
J. Radtke, B. Hadaschik, M. Wolf, Martin T. Freitag +9 more
2015Journal of endourology41 citations
Semantic Scholar
Mutations in BRCA2 and taxane resistance in prostate cancer
Cathleen Nientiedt, Martina Heller, V. Endris, Anna-Lena Volckmar +10 more
2017Scientific Reports39 citations Open access
Semantic Scholar
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker
M. Knoll, S. Macher-Goeppinger, J. Kopitz, S. Duensing +4 more
2015OncoTarget38 citations Open access
Semantic Scholar
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
Angela Queisser, S. Hagedorn, H. Wang, T. Schaefer +10 more
2017Oncogene37 citations
Semantic Scholar
High-risk prostate cancer: a disease of genomic instability.
M. Tapia-Laliena, N. Korzeniewski, M. Hohenfellner, S. Duensing
2014Urologic oncology36 citations
Semantic Scholar
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy.
Xin Chen, Christof Bernemann, Y. Tolkach, Martina Heller +16 more
2017Urologic oncology35 citations
Semantic Scholar
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib
A. von Mässenhausen, C. Sanders, J. Brägelmann, M. Konantz +10 more
2016International Journal of Cancer35 citations Open access
Semantic Scholar
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer
F. Becker, V. Joerg, M. Hupe, Doris Roth +10 more
2020International Journal of Cancer34 citations Open access
Semantic Scholar
Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer
C. Kesch, J. Radtke, Axel Wintsche, M. Wiesenfarth +33 more
2018Scientific Reports34 citations Open access
Semantic Scholar
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
A. Offermann, Silke Hohensteiner, C. Kuempers, J. Ribbat-Idel +10 more
2017Frontiers in Medicine34 citations Open access
Semantic Scholar
Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma
G. Hatiboglu, M. Hohenfellner, A. Arslan, B. Hadaschik +9 more
2017Langenbeck's archives of surgery (Print)33 citations
Semantic Scholar
Revisiting the Role of p53 in Prostate Cancer
Miriam Teroerde, Cathleen Nientiedt, A. Duensing, M. Hohenfellner +2 more
2021Prostate Cancer31 citations Open access
Semantic Scholar
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer
Sabrina Schecher, Britta Walter, M. Falkenstein, S. Macher-Goeppinger +8 more
2017International Journal of Cancer31 citations Open access
Semantic Scholar
Genomic features of renal cell carcinoma with venous tumor thrombus
Gregor Warsow, D. Hübschmann, K. Kleinheinz, Cathleen Nientiedt +24 more
2018Scientific Reports29 citations Open access
Semantic Scholar
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
L. Ratz, M. Laible, L. Kacprzyk, S. Wittig-Blaich +5 more
2017OncoTarget28 citations Open access
Semantic Scholar
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel.
Cathleen Nientiedt, V. Endris, M. Jenzer, J. Mansour +41 more
2020Urologic oncology25 citations Open access
Semantic Scholar
MERTK as a novel therapeutic target in head and neck cancer
A. von Mässenhausen, C. Sanders, Britta Thewes, M. Deng +11 more
2016OncoTarget25 citations Open access
Semantic Scholar
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells
Abigail Allen, D. Gau, Paul G. Francoeur, J. Sturm +11 more
2020Journal of Biological Chemistry24 citations Open access
Semantic Scholar
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer.
Carine Pecqueux, A. Arslan, Martina Heller, M. Falkenstein +10 more
2018Urologic oncology24 citations
Semantic Scholar
IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2.
Constanze Merz, A. von Mässenhausen, Angela Queisser, W. Vogel +5 more
2016American Journal of Pathology24 citations Open access
Semantic Scholar
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer.
Cathleen Nientiedt, J. Budczies, V. Endris, M. Kirchner +35 more
2021Urologic oncology23 citations Open access
Semantic Scholar
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling
A. Offermann, Ignacija Vlašić, I. Syring, W. Vogel +12 more
2016OncoTarget23 citations Open access
Semantic Scholar
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.
S. Vallet, S. Pahernik, T. Höfner, G. Tosev +6 more
2015Clinical Genitourinary Cancer22 citations
Semantic Scholar
Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate Cancer
Christof Bernemann, Verena Humberg, B. Thielen, Julie Steinestel +4 more
2019Clinical Cancer Research21 citations Open access
Semantic Scholar
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S. Eickelschulte, A. Riediger, A. Angeles, F. Janke +3 more
2022Cancers20 citations Open access
Semantic Scholar
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
G. Tosev, W. Wahafu, P. Reimold, I. Damgov +7 more
2021Scientific Reports18 citations Open access
Semantic Scholar
Adjuvant therapy for renal-cell carcinoma: settled for now.
S. Duensing, M. Hohenfellner
2016The Lancet18 citations
Semantic Scholar
PBRM1 (BAF180) protein is functionally regulated by p53‐induced protein degradation in renal cell carcinomas
S. Macher-Goeppinger, M. Keith, K. Tagscherer, S. Singer +8 more
2015Journal of Pathology18 citations
Semantic Scholar
Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability
M. Tapia-Laliena, N. Korzeniewski, Samuel Peña-Llopis, C. Scholl +4 more
2019Oncogenesis17 citations Open access
Semantic Scholar
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
Jana Friedhoff, Felix Schneider, Christina Jurcic, V. Endris +14 more
2022Cancer Immunology and Immunotherapy16 citations Open access
Semantic Scholar
Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer
D. Gau, Andrew Daoud, Abigail Allen, M. Joy +7 more
2023Journal of Biological Chemistry15 citations Open access
Semantic Scholar
The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ϵ–FOXO Pathway
A. Angeles, D. Heckmann, Niclas Flosdorf, S. Duensing +1 more
2020Molecular Cancer Research15 citations
Semantic Scholar
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
Neele Wüstmann, K. Seifert, Verena Humberg, Julia Vieler +9 more
2023Biomarker Research14 citations Open access
Semantic Scholar
Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery
Viktoria Schütz, P. Reimold, Magdalena Goertz, L. Hofer +5 more
2021Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy
S. Dietz, H. Sültmann, Yue-Jun Du, E. Reisinger +9 more
2017OncoTarget14 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Hohenfellner×31
Invite
M. Hohenfellner — researcher profile on SciRah
S. Perner×16
Invite
S. Perner — researcher profile on SciRah
H. Sültmann×15
Invite
H. Sültmann — researcher profile on SciRah
A. Duensing×13
Invite
A. Duensing — researcher profile on SciRah

×12

Invite

B. Hadaschik — researcher profile on SciRah

Invite

W. Roth — researcher profile on SciRah

A. Stenzinger×11

Invite

A. Stenzinger — researcher profile on SciRah

C. Grüllich×11

Invite

C. Grüllich — researcher profile on SciRah

Invite

D. Jäger — researcher profile on SciRah

Invite

J. Kirfel — researcher profile on SciRah

Invite

J. Radtke — researcher profile on SciRah

J. Nyarangi-Dix×9

Invite

J. Nyarangi-Dix — researcher profile on SciRah